Cardioprotective medications and the incidence of cardiovascular events in patients treated with radiotherapy: a systematic review and meta-analysis
Current evidence exploring the impact of cardioprotective medications on CVD risk in patients treated with RT is heterogenous and limited to retrospective non-randomized studies. A considerable proportion of patients undergoing RT are not being prescribed cardioprotective medications as suggested by existing CVD guidelines.
Authors
- Ravi Marwah (ORCID: https://orcid.org/0000-0002-8373-2519)
- V. Pakeerathan
- Justin Smith
- Abdul Rahman Mohammed
Institutions
- Griffith University (AU)
- The University of Queensland (AU)
- Townsville Hospital (AU)
- Princess Alexandra Hospital (AU)
- Sunshine Coast University Hospital (AU)
- Princess Alexandra Hospital (GB)
- James Cook University (AU)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1186/s40959-025-00439-x
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00